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Breaking the Cycle of Pain In
Diabetic Peripheral Neuropathy





An attitude of helplessness pervades both patients and
health professionals when dealing with the problems of dia-
betic peripheral neuropathy. Those afflicted are often over-
whelmed by the pain and find themselves unable to fulfill
the daily requirements of their diabetes regimen. The in-
consistencies in amounts and timing of meals, levels of ac-
tivity, and scheduling of insulin injections can result in
hyperglycemia, a state that has been found to correlate
strongly with the occurrence of nerve damage. Thus the
pain perpetrates itself. For the health professional, having
to confront this devastating pain without objective factors
to assess and few scientific treatment measures to offer con-
tributes to a sense of inadequacy and ignorance. It is fre-
quently assumed that "nothing can be done." In reality,
health professionals do have something to offer the person
suffering from this condition. First, they can provide infor-
mation about the relationship between control and compli-
cations, and explain the need for the patient to change
those behaviors that may be perpetuating the pain. Sec-
ond, and most importantly, health professionals can con-
vey support and confidence, without which many patients
will be unable to make the changes in their behavior neces-
sary to resolve their pain.
Normalizing blood glucose is the goal of therapy in dia-
betes. Although still controversial, much of the current re-
search supports a relationship between poor metabolic con-
trol and diabetic complications. 1,2 In the case of peripheral
neuropathy, the complication itself may interfere with
optimal blood glucose regulation. Severe pain, com-
pounded by its ensuing sleepless nights and depression,
makes adherence to a consistent daily pattern of meals,
injections, activity, and monitoring virtually impossible.
Without a consistent regimen, blood glucose control is un-
likely. In order to minimize the risk and the damage caused
by complications, it is essential that interventions by health
professionals result in enabling patients to maintain their
diabetes regimen and thus optimal blood glucose control.
Clinical Manifestations
The debilitating effects of the condition can be extreme
to the point of causing feelings of profound hopelessness.
A vigorous and positive approach by the health profession-
al is necessary to counteract these feelings and to motivate
patients to begin managing their diabetes more aggressive-
ly. Patients describe their pain as a constant, sharp, electri-
cal tingling or burning sensation, usually in the feet and
legs, and often in the hands. Sometimes putting on clothes
is a torture because the person may suffer from hypersen-
sitivity to touch. Physical activity is severely limited due
to the pain in the lower extremities. With continued disuse
the muscles may atrophy, and in some cases the complica-
tions are similar to those seen with chronic bedrest: loss
of muscle strength and tissue, skin breakdown, and consti-
pation. The pain becomes more severe at night making
sleep difficult, if not impossible. The resultant fatigue further
depletes the person’s ability to tolerate the pain the next
day. Sleep is taken when it comes, often assisted by the
use of pain medication. Thus, during the day when meals
should be planned, prepared, and eaten, and insulin must
be taken, the person may be sleeping or too exhausted
to do what is required.
This is a devasting condition. The pain is all-consum-
ing, unceasing. These people are at the limits of their cop-
ing and depression is not unusual. Ellenberg3 observed de-
pression to be so common that he suggested that it is an
integral part of the condition. Archer’ found the statement
&dquo;life is hardly worth living&dquo; characterized the prevailing atti-
tude of those he studied. Not surprisingly, impotence is
also a common problem for these patients.
Patients feel alone with their pain, not only because
pain is a subjective phenomenon, but because neuropathy
is invisible and little understood. Most patients are not
aware that the condition has a name or that it is related
to their diabetes. They often expect relief through some
external means, such as leg massages. Many are confused
when told the condition originates in their nerves interpret-
ing this to mean that they are &dquo;nervous.&dquo; The condition
often goes unrecognized or untreated by the health profes-
sionals the patient seeks out for help. Watkins has stated,
&dquo;The relative lack of objective evidence for neuropathy
leads to a spurious label of malingering.&dquo;5
Interventions
The health professional’s task begins with a process of
affirmation. The first objective must be to gain the patient’s
trust and establish hope, to name the pain and convey con-
fidence that the problem will be handled. The goal of the
interventions is to help the person work through the pain
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to accomplish the daily requirements of his diabetes regi-
men and thus achieve the best blood glucose regulation
possible. This is essential to establish, since the balance of
scientific evidence weighs heavily in favor of a relationship
between glycemic control and the etiology and manage-
ment of neuropathy. 1,2,4-8
Assessment of the patient can have therapeutic value
as part of the process of affirmation. Through the assess-
ment the health professional can demonstrate an under-
standing of the scope of the problem and its potential im-
pact on the patient. Careful, thorough questioning about
the level and characteristics of the pain, how it affects the
patient’s sleep, activity level, sexual relations, lifestyle, and
diabetes management can reassure the patient that the pain
is understood. Questions about how the patient deals with
the pain at home should be included in the assessment.
Anyone who has lived with constant pain has undoubtedly
tried to find ways to alleviate it. Anything the patient has
found to be successful should be continued in the hospital
if possible. Home use of pain medication should be careful-
ly assessed.
In working toward the goal of breaking the cycle of pain
and changing the behaviors perpetuating the pain, the ap-
proach to the patient is a key factor. Without minimizing
the pain or denying its existence, the health professional
must convey the expectation that the patient will function
despite the pain. Certain measures can be instituted to help
control or cope with the pain. However, it is likely that
the pain may continue to some degree for an indefinite
period of time.
Prognosis
The prognosis for the resolution of the pain seems to
be dependent upon the type of neuropathy involved. Sev-
eral authors’-’ have divided cases into two groups:
1) those with acute onset, usually with the most severe
symptoms, including dramatic weight loss (neuropathic
cachexia), and 2) those with insidious onset in patients with
long-standing diabetes. Patients in the first group with
symptoms of short duration carry a better prognosis, with
resolution of pain in all patients occurring within a few
months to a year, with no recurrence. Symptoms of those
in the second group, however, do not resolve spontane-
ously and may persist for some years. Satisfactory recovery
is less probable, even with adequate glucose control, be-
cause of the likelihood that axons have been lost.8 Evalua-
tion of this group is often problematic due to similarities
in neuropathic and vascular symptoms, and the increasing
frequency of vascular complications in diabetes overtime.
Thus vascular disease may also be a factor in the poor re-
covery. 7,9
It is unclear whether the changes in the nerves of the
patients in both groups are of the same nature. Fry et al.’ 7
pointed out the importance of recognizing different types
of diabetic neuropathy &dquo;for although inadequate control
appears to play a part in the development of them all, their
response to treatment varies and it is likely that they differ
in their pathogenesis.&dquo; This may explain the paradox noted
by many researchers1,3,4,8in which some patients may re-
cover with indifferent control and some fail to recover de-
spite good control. Thomas et al. summarized this contro-
versy and offered the following pragmatic advice: &dquo;Al-
though there is reason to believe that control of blood sugar
is likely to lead to a reduction in the incidence of significant
damage, there seems to be no doubt that some morphol-
ogical changes will occur in most patients despite satisfac-
tory control. There is a reasonable case for blood sugar
control, at least until such time as a more fundamental un-
derstanding of the biochemical abnormalities allows a radi-
cally different therapeutic approach.&dquo;8 This viewpoint has
also been supported more recently in a study by Boulton
et al. who recommended the maintenance of strict capil-
lary blood glucose control in the management of all cases
of painful diabetic neuropathy and the use of continuous
subcutaneous insulin infusion to achieve this.
Daily Routines
While in the hospital patients should be expected to
participate as much as possible in their own diabetes man-
agement. Minimum initial expectations for those who are
severely affected may simply be to awaken at a regular
time each day, to take insulin, and to remain up for the
day except for scheduled rest periods. To the degree they
are able, patients should be included in their own pre-meal
urine or blood testing to monitor their own glucose level.
They should be expected to take meals at scheduled times.
Uneaten food should be reported by the patient and the
carbohydrate portion replaced (with fruit juice or other con-
centrated liquid) to maintain the blood glucose. In certain
cases patients demonstrate severe weight loss, described
by some as neuropathic cachexia.3~5 With these patients
and with those whose depression has caused a lack of ap-
petite and weight loss, special care must be taken in plan-
ning the diet to provide weight-gaining or maintenance
meals, minimizing bulk foods. Six small feedings could also
be considered since smaller portions may be better toler-
ated. However, because more time is required to prepare
six meals than three, the meals should be kept simple to
conserve energy, especially if the patient prepares the
meals.
Expected behaviors regarding performance of diabetes
self-care tasks should be jointly determined and revised as
the patient progresses. In fact, writing down mutual expec-
tations in a contract format is often helpful. (See case his-
tory accompanying article.) Care must be taken to avoid
the trap of bargaining for desired patient behaviors &dquo;when
the pain goes away,&dquo; since it may never go away complete-
ly and the risk for further damage only worsens the longer
the patient &dquo;waits.&dquo; The health professional cannot promise
that the therapeutic measures suggested will eliminate the
pain. One can only honestly offer to help the patient con-
trol the pain.
Methods of Relieving Pain
Pain is a multidimensional phenomenon comprised of
cognitive, emotional, and physical components. The tech-
niques used to treat the pain may deal with one or more
of these components. The choice of which method to use
depends upon which aspect of pain is particularly trouble-
some for that person, and the response will be as individual
as the characteristics of that particular case. Especially in
light of the ambiguity regarding the pathology of neu-
ropathy, it would be a disservice to a patient to exclude
any treatment modality that offered even a slight chance
of providing pain relief.
15
Gate Control Theory
Many of the techniques found useful in treating patients
with chronic pain are based on the gate control theory.
These techniques produce relief by closing a hypothetical
&dquo;gate&dquo; in the spinal cord which prevents pain signals from
reaching the brain. 10 Some of the modalities which are
based on this theory are hypnosis, acupuncture, and the
transcutaneous electronic nerve stimulator (TENS), the lat-
ter having been used preferably in treating painful diabetic
neuropathy. The TENS (see diagram) is a device that emits
gentle electrical signals, controlled by the patient, which
stimulate large nerve fibers, closing the &dquo;gate&dquo; in the spinal
cord and blocking pain signals to the brain. 11 Its advantages
are first, there are no side effects, and second, the patient
gains control over management of the pain relief. If the
device is effective, relief can be achieved in the first session.
If no beneficial effect is noted within 30 minutes following
its application, adjustments may need to be made in the
placement of the electrodes or the settings of the controls. 12
Proper instruction and guidance, both initially and through-
out the use of the device, is essential to its success. Instruc-
tion and units available for rental can often be obtained
through a physical therapy department. Factors that have
been found to increase the likelihood of pain relief with
TENS were, 1) initiating treatment as soon as possible after
the onset of pain, and 2) using TENS in combination with
other treatment modalities
With superficial nerve pain, the hyperesthesia can inter-
fere with wearing clothes comfortably, tolerating bed
covers, enjoying sexual intimacy, and taking injections. In
clinical experiences at the Michigan Diabetes Research and
Training Center, some patients obtained relief by immer-
sion in very warm or very cool water, some by wearing
a body stocking or pantyhose under their clothes to mini-
mize the contact stimulation of the piloerectile nerves. In
addition using a bed cradle at night often relieved the dis-
comfort from bed covers.
Other techniques used to manage the patient’s pain
deal with the cognitive and emotional components of the
pain, modifying the pain experience by altering one’s atti-
tude toward pain. A person may be taught to decrease
the anxiety which accompanies chronic pain through relax-
ation techniques such as rhythmic breathing, biofeedback,
self-distraction, and imagery. Grzesiak stated pain is influ-
enced by anxiety, fear, and anticipation and that &dquo;it is at
the level of these unpleasant emotional states that simple
relaxation procedures appear to alter the pain experi-
ence.&dquo;13 The effectiveness of these techniques is attributed
to the notion that deep muscle relaxation and anxiety or
the experience of pain are incompatible states.13
Medication
The method most commonly used to treat neuropathic
pain is medication. Selective use of medication is critical
in managing chronic pain. Some pain medications may
actually aggravate the pain by causing a rebound, or an
exaggerated pain response as the medication wears off.
It is best to avoid the use of narcotic analgesics for treatment
of chronic pain due to the potential for developing de-
pendence on them.$ 8
Certain medications have been used specifically for
neuropathic pain. These include phenytoin or diphenylhy-
dantoin (Dilantin) , which is one of the earlier drugs used
for this condition, carbamazepine (Tegretol),4,5,8 and
fluphenazine (Prolixin) alone or in combination with a
tricyclic antidepressant usually amitriptyline (Elavil) or
nortriptyline.4,5,14 Antidepressants may also be used
alone. For example, amitriptyline administered at bedtime
in a dose of 50-100 mg often enables the patient to sleep.
This relief of insomnia was identified by Archer as &dquo;one
of the most important facets of treatment,&dquo;6 contributing
to an improved sense of well being. Pain relief from try-
cyclic antidepressants is speculated to be a result of in-
creased cortical inhibition of sensory input and/or possibly
due to mood alteration, although the doses used are lower
than psychotherapeutic levels. 14 Another researcher&dquo; has
reported dramatic relief of pain and numbness using
trazodone hydrochloride (Desyrel) which is also an antide-
pressant, though chemically unrelated to the tricyclic or
tetracyclic types. He noted more rapid onset of relief and
fewer side effects compared to tricyclics.
Current investigations have been concerned with the
effectiveness of the drug Sorbinil, an aldose reductase in-
hibitor. Some forms of diabetic neuropathy are felt to be
a result of sorbitol accumulation, and the segmental de-
myelinization found in some diabetic neuropathy has been
attributed to this mechanism.~ Sorbinil has been shown to
provide considerable relief of severe neuropathic pain in
diabetic patients, along with a substantial improvement in
sleep patterns and overall mood and morale.&dquo;
One final note about pain relief: nurses working with
patients on the Diabetes Center Unit at the Michigan Dia-
betes Research and Training Center in Ann Arbor recently
began to recommend the local application of analgesic
balm (i.e., Ben Gay@) to their patients with neuropathic
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pain, after having received several positive reports from
patients who had tried it. 17 There may be several explana-
tions for its success, including a placebo effect. However,
it is likely there are no negative side effects and it may war-
rant further investigation.
Rehabilitation
In addition to interventions aimed at managing the
pain, consideration must be given to the effects of the pain
and how it has changed the person’s ability to live his daily
life. A potential secondary complication of neuropathy is
muscle atrophy due to disuse and denervation.8 This may
have advanced to the point where patients cannot bear
their own weight. In these and other less severe cases,
physical and occupational therapy can set up a progressive
activity schedule and strengthening exercises, and recom-
mend assistive or safety devices. Other referrals might also
be indicated, such as psychiatric counseling to assist the
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patient in dealing with the reality of the condition and its
limitations. A social worker might be asked to inform the
patient about financial assistance especially if the neu-
ropathy has impaired the ability to work. Vocational Re-
habilitation may be appropriate to retrain the patient in new
job skills or to negotiate with the employer to alter the job
situation as necessary (e.g., schedule rest periods or reas-
signment to a task which does not require standing). Visit-
ing nurses may assist in implementing the contract for pro-
gressive physical activity and diabetes management once
the patient returns home.
Education
Educating patients is essential to soliciting their full par-
ticipation. Much of the process of neuropathy is unfamiliar
to them, and their anxiety and fear about the unknown
can potentiate the experience of pain. The more the mys-
tery can be dispelled, the more they may be motivated to
change those behaviors that contribute to hyperglycemia.
Pain and anxiety may impair a person’s learning ability.
One should plan sessions for teaching about neuropathy
and negotiating for expected behaviors at times when the
patient is well rested and alert. Rationales and explanations
should be repeated patiently when contractual goals are
not met or if questions arise. The family needs to be in-
cluded in the entire treatment process. Because neu-
ropathy is invisible it is not unusual for families to be short
on sympathy, or even to think the patient is &dquo;faking.&dquo; They
should be helped to understand what is happening.
The following factors are important in planning the edu-
cation of patients and their families:
1. Describe clearly the relationship between blood glucose
levels and neuropathy and the importance of the daily
diabetes regimen to ultimate resolution of their symp-
toms. Care should be taken not to communicate blame
to the patient in making this explanation. It is not &dquo;all
his fault&dquo; that he has neuropathy. Although there is
some relationship between blood glucose levels and
complications, not all persons with poor blood glucose
control develop complications and some with good con-
trol do. Emphasize that something may be done to arrest
the progression of complications with strict blood glu-
cose regulation.
2. Make it clear to patients that neuropathy refers to the
nerves of the body and it does not mean &dquo;nervous.&dquo;
3. Counsel the patient that although there may be im-
provement of pain with adequate control of blood glu-
cose, it is possible that there may be some residual
paresthesia or numbness, depending on the extent of
damage to the nerves.
4. Prepare patients who undergo diagnostic testing for
neuropathy by electromyography (EMG) for the fact
that the test is often uncomfortable and some find it
painful.
In summary, it can be seen that health professionals
certainly do have something to offer patients suffering from
painful neuropathy. The greatest need these patients have
is for validation and affirmation of what they are experienc-
ing, and reassurance that others who have suffered from
the same problem have improved. Conveying confidence
and hope can make the difference for those who, in con-
fusion and pain, are giving up. With support they may be
inspired to function despite their pain, to resume the tasks
necessary to maintain glycemic control, and break the cycle
of pain. D
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